Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1830)
Metagenomi Therapeutics, Inc. (MGX)
Wein Matthew — General Counsel, Compliance Officer and Corporate Secretary
Shares
558
Price
$1.30
Total Value
$724.84
Shares Held After
126,491
% of Holdings
0.4%
Metagenomi Therapeutics, Inc. (MGX)
Irish Jian — Director
Shares
3,737
Price
$1.30
Total Value
$4.85K
Shares Held After
377,533
% of Holdings
1.0%
Natera, Inc. (NTRA)
Marcus Gail Boxer — Director
Shares
116
Price
$218.81
Total Value
$25.38K
Shares Held After
6,183
% of Holdings
1.8%
Natera, Inc. (NTRA)
Marcus Gail Boxer — Director
Shares
3,174
Price
$218.11
Total Value
$692.28K
Shares Held After
6,299
% of Holdings
33.5%
Natera, Inc. (NTRA)
Marcus Gail Boxer — Director
Shares
4,694
Price
$217.30
Total Value
$1.02M
Shares Held After
9,473
% of Holdings
33.1%
Natera, Inc. (NTRA)
Marcus Gail Boxer — Director
Shares
3,016
Price
$216.06
Total Value
$651.65K
Shares Held After
14,167
% of Holdings
17.6%
ANI PHARMACEUTICALS INC (ANIP)
CAREY STEPHEN P. — SVP & CFO
Shares
3,312
Price
$80.00
Total Value
$264.96K
Shares Held After
180,393
% of Holdings
1.8%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$19.27
Total Value
$19.27K
Shares Held After
43,415
% of Holdings
2.3%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
3,500
Price
$19.46
Total Value
$68.11K
Shares Held After
42,415
% of Holdings
8.3%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
6,000
Price
$19.48
Total Value
$116.88K
Shares Held After
38,915
% of Holdings
15.4%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
10,000
Price
$19.41
Total Value
$194.10K
Shares Held After
32,915
% of Holdings
23.3%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
500
Price
$19.44
Total Value
$9.72K
Shares Held After
42,915
% of Holdings
1.2%
NEUROCRINE BIOSCIENCES INC (NBIX)
SHERWIN STEPHEN A — Director
Shares
1,843
Price
$167.31
Total Value
$308.36K
Shares Held After
15,860
% of Holdings
10.4%
NEUROCRINE BIOSCIENCES INC (NBIX)
SHERWIN STEPHEN A — Director
Shares
5,829
Price
$166.56
Total Value
$970.86K
Shares Held After
17,703
% of Holdings
24.8%
NEUROCRINE BIOSCIENCES INC (NBIX)
SHERWIN STEPHEN A — Director
Shares
6,896
Price
$165.79
Total Value
$1.14M
Shares Held After
23,532
% of Holdings
22.7%
NEUROCRINE BIOSCIENCES INC (NBIX)
SHERWIN STEPHEN A — Director
Shares
2,549
Price
$164.44
Total Value
$419.16K
Shares Held After
30,428
% of Holdings
7.7%
NEUROCRINE BIOSCIENCES INC (NBIX)
SHERWIN STEPHEN A — Director
Shares
7,883
Price
$163.81
Total Value
$1.29M
Shares Held After
32,977
% of Holdings
19.3%
Butterfly Network, Inc. (BFLY)
Cashman Steve — Chief Business Officer
Shares
104,781
Price
$4.96
Total Value
$520.13K
Shares Held After
1,925,087
% of Holdings
5.2%
Enliven Therapeutics, Inc. (ELVN)
Kunkel Lori Anne — Director
Shares
354
Price
$35.82
Total Value
$12.68K
Shares Held After
51,884
% of Holdings
0.7%
Enliven Therapeutics, Inc. (ELVN)
Kunkel Lori Anne — Director
Shares
1,867
Price
$35.36
Total Value
$66.01K
Shares Held After
52,238
% of Holdings
3.5%
Enliven Therapeutics, Inc. (ELVN)
Kunkel Lori Anne — Director
Shares
7,779
Price
$34.28
Total Value
$266.66K
Shares Held After
54,105
% of Holdings
12.6%
GLOBUS MEDICAL INC (GMED)
Davidar David D — Director
Shares
25,000
Price
$80.76
Total Value
$2.02M
Shares Held After
510,175
% of Holdings
4.7%
MYOMO, INC. (MYO)
KIRK THOMAS F — Director
Shares
40,002
Price
$1.27
Total Value
$50.80K
Shares Held After
693,865
% of Holdings
5.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
1,745
Price
$450.00
Total Value
$785.25K
Shares Held After
21,015
% of Holdings
7.7%
ILLUMINA, INC. (ILMN)
Leckman Patricia — SVP, Chief People Officer
Shares
2
Price
$167.88
Total Value
$335.76
Shares Held After
21,259
% of Holdings
0.0%
ILLUMINA, INC. (ILMN)
Leckman Patricia — SVP, Chief People Officer
Shares
39
Price
$164.82
Total Value
$6.43K
Shares Held After
21,261
% of Holdings
0.2%
ILLUMINA, INC. (ILMN)
Leckman Patricia — SVP, Chief People Officer
Shares
78
Price
$163.36
Total Value
$12.74K
Shares Held After
21,300
% of Holdings
0.4%
ILLUMINA, INC. (ILMN)
Leckman Patricia — SVP, Chief People Officer
Shares
374
Price
$162.78
Total Value
$60.88K
Shares Held After
21,378
% of Holdings
1.7%
ILLUMINA, INC. (ILMN)
Leckman Patricia — SVP, Chief People Officer
Shares
290
Price
$161.79
Total Value
$46.92K
Shares Held After
21,752
% of Holdings
1.3%
Medline Inc. (MDLN)
CORCORAN JESSI L — Principal Accounting Officer
Shares
5,000
Price
$34.15
Total Value
$170.75K
Shares Held After
5,000
% of Holdings
100.0%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
3,500
Price
$2.05
Total Value
$7.17K
Shares Held After
11,279
% of Holdings
31.0%
Xenon Pharmaceuticals Inc. (XENE)
Cannon Gillian — Director
Shares
1,190
Price
$53.14
Total Value
$63.24K
Shares Held After
1,455
% of Holdings
45.0%
Xenon Pharmaceuticals Inc. (XENE)
PATOU GARY — Director
Shares
1,322
Price
$53.14
Total Value
$70.25K
Shares Held After
24,896
% of Holdings
5.0%
Guardant Health, Inc. (GH)
Eltoukhy Helmy — Director
Shares
100
Price
$132.55
Total Value
$13.26K
Shares Held After
2,012,919
% of Holdings
0.0%
Guardant Health, Inc. (GH)
Eltoukhy Helmy — Director
Shares
900
Price
$131.78
Total Value
$118.61K
Shares Held After
2,013,019
% of Holdings
0.0%
Guardant Health, Inc. (GH)
Eltoukhy Helmy — Director
Shares
554
Price
$130.21
Total Value
$72.13K
Shares Held After
2,013,919
% of Holdings
0.0%
Guardant Health, Inc. (GH)
Eltoukhy Helmy — Director
Shares
13,787
Price
$128.25
Total Value
$1.77M
Shares Held After
2,014,473
% of Holdings
0.7%
Guardant Health, Inc. (GH)
Eltoukhy Helmy — Director
Shares
1,100
Price
$127.02
Total Value
$139.73K
Shares Held After
2,028,260
% of Holdings
0.1%
Guardant Health, Inc. (GH)
Eltoukhy Helmy — Director
Shares
33,843
Price
$126.33
Total Value
$4.28M
Shares Held After
2,029,360
% of Holdings
1.6%
Guardant Health, Inc. (GH)
Eltoukhy Helmy — Director
Shares
49,716
Price
$125.57
Total Value
$6.24M
Shares Held After
2,063,203
% of Holdings
2.4%
Guardant Health, Inc. (GH)
Bell Michael Brian — Chief Financial Officer
Shares
2,000
Price
$128.62
Total Value
$257.24K
Shares Held After
47,509
% of Holdings
4.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
4,415
Price
$68.96
Total Value
$304.46K
Shares Held After
4,318,447
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
8,437
Price
$67.88
Total Value
$572.74K
Shares Held After
4,322,862
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
7,148
Price
$67.20
Total Value
$480.34K
Shares Held After
4,331,299
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
4,416
Price
$68.96
Total Value
$304.52K
Shares Held After
515,686
% of Holdings
0.8%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
8,437
Price
$67.88
Total Value
$572.74K
Shares Held After
520,102
% of Holdings
1.6%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
7,147
Price
$67.20
Total Value
$480.27K
Shares Held After
528,539
% of Holdings
1.3%
SI-BONE, Inc. (SIBN)
DUNN JEFFREY W — Director
Shares
3,575
Price
$15.25
Total Value
$54.51K
Shares Held After
16,057
% of Holdings
18.2%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
735,462
Price
$0.06
Total Value
$45.60K
Shares Held After
0
% of Holdings
100.0%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
24,946
Price
$0.40
Total Value
$9.98K
Shares Held After
437,758
% of Holdings
5.4%
Showing 151–200 of 1830 transactions (page 4 of 37)